Laura Pat Svetkey, MD

Professor of Medicine
Director of Clinical Research
Vice-chair for Faculty Development & Diversity in the Department of Medicine
Campus mail Duke Box 3703, Durham, NC 27710
Phone (919) 681-6386
Email address svetk001@mc.duke.edu

Laura P. Svetkey, MD MHS is Professor of Medicine/Nephrology, Vice Chair for Faculty Development and Diversity in the Department of Medicine, and School of Medicine Faculty Ombudsperson. She is also the Director of Duke’s CTSA-sponsored internal career development award program (KL2) and the Investigator Development Core of Duke’s REACH Equity Disparities Research Center.

Dr. Svetkey has over 30 years of experience in the investigation of hypertension, obesity, and related areas, conducting NIH-sponsored clinical research ranging from behavioral intervention trials to metabolomics and genetics, with a consistent focus on prevention, non-pharmacologic intervention, health disparities and minority health. Her research has affected national guidelines, having served on the 2013 national Hypertension Guideline Panel (JNC) and the Lifestyle Guideline Working Group. She is an American Society of Hypertension certified hypertension specialist, and a member of the Association of American Physicians (AAP). She is the Associate Director, Core Director and Project PI of Duke’s REACH Equity Disparities Research Center.

As Department of Medicine Vice Chair for Faculty Development and Diversity, she implements a wide range of programs to enhance the experience and advancement of faculty and trainees, with particular emphasis on under-represented minorities and women.

As School of Medicine Faculty Ombudsperson, she helps faculty resolve concerns by providing confidential, impartial, informal guidance.

Education and Training

  • Fellow in General Internal Medicine, Medicine, Duke University, 1982 - 1983
  • Resident in Medicine, Medicine, Montefiore Medical Center, 1980 - 1982
  • Intern in Medicine, Medicine, Montefiore Medical Center, 1979 - 1980
  • M.D., Harvard University , 1979

Publications

Sharma, L. P., E. J. Lewis, R. Rohde, R. P. Bain, P. K. Burrows, S. L. Edelstein, M. Pohl, et al. “Erratum: Captopril-induced reduction of serum levels of transforming growth factor-β1 correlates with long-term renoprotection in insulin- dependent diabetic patient's (American Journal of Kidney Diseases (1999) 34(818-823)).” American Journal of Kidney Diseases 35, no. 3 (2000).

Scholars@Duke

Fielding, R. A., M. A. Violan, L. Svetkey, L. W. Abad, T. J. Manfredi, A. Cosmas, and J. Bean. “Effects of prior exercise on eccentric exercise-induced neutrophilia and enzyme release.” Medicine and Science in Sports and Exercise 32, no. 2 (2000): 359–64.

Scholars@Duke

Getchell, W. S., L. P. Svetkey, L. J. Appel, T. J. Moore, G. A. Bray, and E. Obarzanek. “Summary of the Dietary Approaches to Stop Hypertension (DASH) Randomized Clinical Trial..” Curr Treat Options Cardiovasc Med 1, no. 4 (December 1999): 295–300. https://doi.org/10.1007/s11936-999-0024-6.

PMID
11096495
Full Text

Conlin, P. R., A. D. Bohannon, E. R. Miller, L. J. Appel, T. P. Erlinger, J. Hopkins, L. P. Svetkey, and T. J. Moore. “The DASH diet enhances the blood pressure response to losartan in African American hypertensive patients.” Circulation 100, no. 18 (November 2, 1999): 807–807.

Scholars@Duke

Moore, T. J., W. M. Vollmer, L. J. Appel, F. M. Sacks, L. P. Svetkey, T. M. Vogt, P. R. Conlin, D. G. Simons-Morton, L. Carter-Edwards, and D. W. Harsha. “Effect of dietary patterns on ambulatory blood pressure : results from the Dietary Approaches to Stop Hypertension (DASH) Trial. DASH Collaborative Research Group..” Hypertension 34, no. 3 (September 1999): 472–77. https://doi.org/10.1161/01.hyp.34.3.472.

PMID
10489396
Full Text

Plaisted, C. S., P. H. Lin, J. D. Ard, M. L. McClure, and L. P. Svetkey. “The effects of dietary patterns on quality of life: a substudy of the Dietary Approaches to Stop Hypertension trial..” J Am Diet Assoc 99, no. 8 Suppl (August 1999): S84–89. https://doi.org/10.1016/s0002-8223(99)00421-6.

PMID
10450299
Full Text

Vogt, T. M., L. J. Appel, E. Obarzanek, T. J. Moore, W. M. Vollmer, L. P. Svetkey, F. M. Sacks, et al. “Dietary Approaches to Stop Hypertension: rationale, design, and methods. DASH Collaborative Research Group..” J Am Diet Assoc 99, no. 8 Suppl (August 1999): S12–18. https://doi.org/10.1016/s0002-8223(99)00411-3.

PMID
10450289
Full Text

Svetkey, L. P., F. M. Sacks, E. Obarzanek, W. M. Vollmer, L. J. Appel, P. H. Lin, N. M. Karanja, et al. “The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group..” J Am Diet Assoc 99, no. 8 Suppl (August 1999): S96-104. https://doi.org/10.1016/s0002-8223(99)00423-x.

PMID
10450301
Full Text

Svetkey, L. P., F. M. Sacks, E. Obarzanek, W. M. Vollmer, L. J. Appel, P. H. Lin, N. M. Karanja, et al. “The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group..” Journal of the American Dietetic Association 99, no. 8 Suppl (August 1999): S96-104. https://doi.org/10.1016/s0002-8223(99)00423-x.

Full Text

Pages